Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank29
5Y CAGR-25.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-25.0%/yr
Long-term compound
Percentile
P29
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$15000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$63000.00-3.1%
2019$65000.00-71.1%
2018$225000.00-39.5%
2017$372000.00-17.4%
2016$450266.00-